as on September 13, 2025 at 1:29 am IST
Day's Low
Day's High
2.40%
Downside
4.00%
Upside
52 Week's Low
52 Week's High
80.60%
Downside
17.60%
Upside
Check Ovid Therapeutics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$88.9M
EPS (TTM)
-0.48
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
-2.86
Industry PE ratio
0P/B Ratio
0PEG Ratio
0EBITDA
-41.2M
Revenue (TTM)
6.7M
Profit Margin
0.00%
Return On Equity TTM
174034400.00%
Track how Ovid Therapeutics Inc P/E has moved over time to understand its valuation trends.
Ovid Therapeutics Inc in the last 5 years
Lowest (1.69x)
December 31, 2021
Industry (0.00x)
September 13, 2025
Today (-2.86x)
September 13, 2025
Highest (2.35x)
June 30, 2021
Today’s Price to Earnings Ratio: -2.86x
Compare market cap, revenue, PE, and other key metrics of Ovid Therapeutics Inc with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
---|---|---|---|---|---|
BUY | $88.9M | -77.93% | -2.86 | 0.00% | |
BUY | $61.1B | 280.5% | -505.15 | -12.96% | |
NA | $37.7B | NA | NA | -3.89% | |
BUY | $101.2B | 54.04% | 28.08 | 31.86% | |
BUY | $59.4B | 2.03% | 14.11 | 31.37% |
The Ovid Therapeutics Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Ovid Therapeutics Inc investment value today
Current value as on today
₹1,10,181
Returns
₹10,181
(+10.18%)
Returns from Ovid Therapeutics Inc Stock
₹5,042 (+5.04%)
Dollar Returns*
₹5,139 (+5.14%)
Based on 16 analysts
87.50%
Buy
12.50%
Hold
0.00%
Sell
Based on 16 analysts, 87.5% of analysts recommend a 'BUY' rating for Ovid Therapeutics Inc. Average target price of $3.4
Get share price movements and forecasts by analysts on Ovid Therapeutics Inc.
What analysts predicted
63.24%UPSIDE
Target Price
$3.4
Current Price
$1.25
Analyzed by
16 Analysts
Target
$3.40
Ovid Therapeutics Inc target price $3.4, a slight upside of 63.24% compared to current price of $1.25. According to 16 analysts rating.
Search interest for Ovid Therapeutics Inc Stock has decreased by -11% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Revenue Rich
Revenue is up for the last 3 quarters, 76.0K → 6.27M (in $), with an average increase of 69.7% per quarter
Price Rise
In the last 3 months, OVID stock has moved up by 347.9%
Profit Spike
Netprofit is up for the last 2 quarters, -10.23M → -4.68M (in $), with an average increase of 118.5% per quarter
Against Peers
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 75.7% return, outperforming this stock by 70.2%
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 123.5% return, outperforming this stock by 166.2%
Organisation | Ovid Therapeutics Inc |
Headquarters | 441 Ninth Avenue, New York, NY, United States, 10001 |
Industry | Health Technology |
CEO | Dr. Jeremy Max Levin Ba Zoology, Dphil, M.D., Mb Bchir, Ph.D. |
E-voting on shares | Click here to vote |
Name | Title |
---|---|
Dr. Jeremy Max Levin Ba Zoology, Dphil, M.D., Mb Bchir, Ph.D. | CEO & Chairman |
Ms. Margaret Alexander | President & COO |
Dr. Dirk Haasner | Senior Vice President of Global Manufacturing & CMC QA |
Dr. Manal Morsy M.B.A., M.D., PH.D. | Chief Regulatory Officer |
Dr. Toshiya Nishi D.V.M. | Head of Epilepsy Research |
Ms. Victoria Fort | Senior Vice President of Corporate Affairs & Corporate Strategy |
Mr. Jeffrey A. Rona | Chief Business and Financial Officer |
Dr. Zhong Zhong Ph.D. | Chief Scientific Officer |
Dr. Amanda Banks M.D. | Chief Development Officer |
Dr. Julia Tsai Ph.D. | Senior Vice President of Clinical Development |
Ovid Therapeutics Inc share price today is $1.25 as on at the close of the market. Ovid Therapeutics Inc share today touched a day high of $1.3 and a low of $1.22.
Ovid Therapeutics Inc share touched a 52 week high of $1.47 on and a 52 week low of $0.24 on . Ovid Therapeutics Inc stock price today i.e. is closed at $1.25,which is 14.97% down from its 52 week high and 415.46% up from its 52 week low.
Ovid Therapeutics Inc market capitalisation is $0.00T as on .
Indian investors can start investing in Ovid Therapeutics Inc (OVID) shares with as little as ₹88.27 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹882.70 in Ovid Therapeutics Inc stock (as per the Rupee-Dollar exchange rate as on ).
Based on Ovid Therapeutics Inc share’s latest price of $1.25 as on September 13, 2025 at 1:29 am IST, you will get 8.0000 shares of Ovid Therapeutics Inc. Learn more about
fractional shares .
Ovid Therapeutics Inc stock has given -77.93% share price returns and 20.01% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?